Before Christmas 2021, healthcare stakeholders curafutura, with SWICA and FMH (Swiss Medical Association) submitted a substantially revised and final version (1.3) of TARDOC for approval.
U.S. Lab Test Reimbursement Rates: What’s New(s)? (updated January, 2020)
U.S. Lab Test Reimbursement Rates: What’s New(s)?
Payer Trends in Diagnostics & Digital Health – What’s new?
Last year we released a blog post on 5 recent Payer trends in Diagnostics. What are the latest developments? Check out this short summary:
Growing appetite for diagnostics health technology assessment in Europe
Joint (regulator-payer) evidence reviews and scientific advice to MedTech manufacturers gain further momentum in the US
Payers start to embrace Digital Health
5 Payer trends in Diagnostics
In Vitro Diagnostics is going through exciting times. Pricing, reimbursement, policy topics are getting more and more relevant in the industry.
We have summarized 5 recent Payer trends, shaping the industry.
Do you want to have the collection of the supporting trend examples, please drop us a line.
Do you see other relevant trends that we might have missed, please comment.